Strong evidence from a new 6-hospital study could lead many ORs to change their traditional practice for surgical skin preparation. In the first prospective, randomized study to compare the effect of 2 skin prep agents on the incidence of surgical site infections (SSIs) after clean-contami-nated surgery, a chlorhexidine (CHG)-alcohol product came out ahead of a povidone-iodine scrub and paint, resulting in an infection rate 41% lower. The report is in the January 7, 2010, New England Journal of Medicine.
The 4-year study led by Rabih O. Darouiche, MD, involved 849 patients having clean-contaminated surgery—409 were prepped with a product containing 2% CHG and 70% isopropyl alcohol (Chlo-raPrep), and 440 were prepped with 10% povidone-iodine. The CHG-alcohol group had an SSI rate of 9.5% compared with 16.1% in the povidone-iodine group, showing a significant difference.
Asked why the infection rates in the study seemed high, Dr Darouiche responded that in this study, as in others, the SSI rates were assessed at30 days postoperatively.
“Unfortunately, most reported rates of SSI underestimate the true rates,” he says, “because they assess SSIs after a relatively short time; that is, at the time of hospital discharge or at the time of the postop clinic visit.”
Dr Darouiche is professor of medicine and director of the Center of Prostheses Infection at Baylor College of Medicine in Houston.
“This is a well-done, randomized, controlled study,” an infection control expert, Richard P. Wenzel, MD, told OR Manager.
“I would say this is a dramatic response for something that’s fairly inexpensive and that doesn’t add time to the procedure,” says Dr Wenzel, an epidemiologist and professor of internal medicine at Vir-gina Commonwealth University, Richmond, who wrote an editorial accompanying the study.
Another recent study by Swenson et al from the University of Virginia Health System, Char-lottesville, had a different result and a different research design. The researchers compared the effects of 3 skin preps—povidone-iodine scrub and paint with isopropyl alcohol between steps, CHG-alcohol (Chlo-raPrep), and iodine povacrylex-al-cohol (DuraPrep)—used in 3 different periods over 6 months. The lowest infection rate was seen in period 3 when iodine povacrylex-alcohol was used. The study was not randomized or blinded and was conducted in a single center. The authors say the study would need to be repeated in more hospitals before one skin prep method could be recommended over another.

Dr Darouiche told OR Manager that he and his colleagues considered 4 factors in comparing the CHG-alcohol and povidone-iodine skin preps:
Both products had similar broad-spectrum antimicrobial activity, but the CHG-alcohol had the upper hand for the other 3 factors:
Dr Darouiche noted that the cost of the povidone-iodine prep tray used in the study was about $3, and the cost of the CHG-alcohol applicator was about $6. On average, 2 applicators were used, depending on the size of the incision, for a total cost of $12 for the CHG-alcohol, a difference of $9 per patient.
Based on the study results, CHG-alcohol prevents at least 6 more cases of infection per 100 patients than povidone-iodine. The $900 in additional cost for CHG-al-cohol for 100 patients is far less than the cost of treating 6 patients with SSIs.
Based on the study’s finding that about 17 patients would need to have skin prep with CHG-alcohol rather than povidone-iodine to prevent one infection, times the difference in price, the cost to the facility is still under $200, says Dr Wenzel. Duke researchers recently reported that a single case of methicillin resistant Staphylococcus aureus resulted in $60,000 in additional charges compared with uninfected controls.
The protection given by CHG-al-cohol in the study was similar to the 49% reduction in vascular catheter-related bloodstream infections in ICUs in a meta-analysis that also found CHG superior to povidone-iodine, the authors note.
Dr Wenzel says the weight of the evidence from this study suggests that CHG-alcohol should replace povidone-iodine as the standard for preoperative skin preparation.
“If we have 300,000 to 500,000 infections in 30 million operations each year, and we can reduce that by some 40%, we’re looking at potentially 120,000 fewer infections. It would be an important change that would have a big yield,” he noted.
In selecting skin antiseptics, AORN recommends assessing patients for allergies to antiseptics— CHG and povidone-iodine have both triggered allergic reactions.
AORN also notes that alcohol-based products pose fire and chemical skin burn risks. Products with alcohol must be allowed to dry thoroughly before drapes are applied to reduce the fire risk.
Dr Daruoiche notes that 3 patients each in the povidone-iodine group and in the CHG-alcohol group had pruritus, erythema, or both around the incision linked to the skin prep solutions. There were no serious allergic reactions, chemical skin burns, or fires in the operating room.
The Centers for Disease Control and Prevention (CDC) “Guidelines for the prevention of intravascular catheter-related infections” recommend 2% CHG-based preparations for cleaning vascular catheter insertion sites. But the CDC does not recommend which antiseptics to use for the preop skin prep.
“Overall,” says Dr Wenzel, “the consistency with which CHG-alcohol has been shown to reduce infections is very strong, and the research supports a change of standard practice.”
Cardinal Health funded the study and provided both skin-prep products. (ChloraPrep is now sold by CareFusion.) Dr Darouiche says the companies had no access to the data.
—Judith M. Mathias, RN, MA
Anderson D J, Kaye K S, Chen L F, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: A multi-center matched outcomes study. PLoS One. 2009;4:1-8.
AORN. Recommended practices for preoperative patient skin antisepsis. Perioperative Standards and Recommended Practices. Denver, CO: AORN, 2010, pp 351-369.
Chaiyakunapruk N, Veenstra D L, Lipsky B A, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med. 2002;136:792-801.
Darouiche R O, Wall M J, Itani K M F, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18-26.
Kirkland K B, Briggs J P, Trivette S L, et al. The impact of surgical site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol.1999;20:725-730.
Napolitano L M. Decolonizamtion of the skin of the patient and surgeon. Surg Infect. 2006;7:Suppl 3:S3-S15.
O’Grady N P, Alexander M, Dellinger E P, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23:759-769.
Swenson B R, Hedrick T L, Metzger R, et al. Effects of preoperative skin preparation on postoperative wound infection rates: A prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol. October 2009;30:964-971.
Wenzel R P. Minimizing surgical-site infections. Editorial. N Engl J Med. 2010;362:75-77.
Yasunaga H, Ide H, Imamura T, et al. Accuracy of economic studies on surgical site infection. J Hosp Infect. 2007;65:102-107.